Thursday, December 18, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Tapestry Shares Poised for Significant Growth Ahead of Earnings

Andreas Sommer by Andreas Sommer
November 1, 2025
in Analysis, Consumer & Luxury, Earnings
0
Tapestry Stock
0
SHARES
13
VIEWS
Share on FacebookShare on Twitter

A notable institutional move has positioned Tapestry for increased investor attention. Transcend Capital Advisors LLC established a new stake in the luxury goods conglomerate during the second quarter, acquiring 2,527 shares valued at approximately $222,000. This strategic investment precedes the company’s imminent quarterly earnings release scheduled for next week.

Upcoming Quarterly Report Fuels Optimism

Market anticipation is building for Tapestry’s first-quarter fiscal 2026 results, set for publication on Thursday. Financial analysts at Zacks Investment Research project earnings per share will reach $1.25, representing a substantial 22.6 percent year-over-year increase. Revenue expectations are equally promising, with forecasts pointing to $1.64 billion—an 8.7 percent growth compared to the same period last year. Notably, the consensus EPS estimate was recently revised upward from $1.21 to $1.25 over the past month, indicating strengthening confidence among market researchers.

Should investors sell immediately? Or is it worth buying Tapestry?

Wall Street Analysts Express Strong Confidence

The investment community appears overwhelmingly bullish on Tapestry’s prospects. Goldman Sachs maintains a “Buy” recommendation with a $130 price target, while Barclays raised its target to $127 with an “Overweight” rating. Raymond James Financial echoes this positive sentiment with a matching $130 price objective and an “Outperform” assessment. UBS presents a more cautious stance with a $105 target and “Neutral” rating. Overall, eighteen analysts recommend buying the stock, with five maintaining “Hold” positions.

Strategic Initiatives and Shareholder Returns Provide Additional Momentum

Beyond immediate earnings expectations, Tapestry continues to demonstrate commitment to shareholder value through a recent dividend increase. The company raised its quarterly dividend from $0.35 to $0.40 per share. This enhanced distribution complements the recently unveiled “Amplify” growth strategy, presented in September, which outlines ambitious targets including mid-single-digit revenue growth and an operating margin exceeding 22 percent by fiscal 2027/2028. The upcoming quarterly report will offer crucial insight into whether Tapestry remains on track to achieve these strategic objectives.

Ad

Tapestry Stock: Buy or Sell?! New Tapestry Analysis from December 18 delivers the answer:

The latest Tapestry figures speak for themselves: Urgent action needed for Tapestry investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 18.

Tapestry: Buy or sell? Read more here...

Tags: Tapestry
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Abbott Laboratories Stock
Analysis

Abbott Laboratories: Dividend Hike and Acquisition Speculation Drive Investor Focus

December 18, 2025
Marvell Technology Stock
AI & Quantum Computing

Marvell Technology: A Tale of Conflicting Market Signals

December 18, 2025
Rocket Lab USA Stock
Analysis

Rocket Lab CEO’s Major Stock Sale Coincides with Key Space Force Launch

December 18, 2025
Next Post
Franklin Stock

Franklin Resources Faces Critical Test with Upcoming Earnings

NASDAQ 100 Stock

Tech Rally's Fragile Foundation: Amazon's Surge Masks Nasdaq 100 Weakness

Robinhood Stock

All Eyes on Robinhood as Quarterly Report Approaches

Recommended

Finance_Fiscal (3)

Analyst Initiates Coverage on GoodRx Holdings with Outperform Rating and 8 Price Target

2 years ago
Occidental Petroleum Stock

Occidental Petroleum Faces Analyst Caution Despite Debt Reduction Progress

4 months ago
Nestle Stock

Nestlé Divests Troubled Coffee Chain in Strategic Overhaul

1 week ago
Ballard Power Stock

Ballard Power Stock: Struggles Amid Strategic Shift

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Geely Extends $600 Million Lifeline to Struggling EV Maker Polestar

Marvell Technology: A Tale of Conflicting Market Signals

Rocket Lab CEO’s Major Stock Sale Coincides with Key Space Force Launch

UnitedHealth’s Strategic Pivot Amidst Political and Financial Headwinds

European Lithium Expands Critical Minerals Footprint with Dual Developments

Barrick Gold Clears Major Hurdle as Mali Dispute Resolves

Trending

Abbott Laboratories Stock
Analysis

Abbott Laboratories: Dividend Hike and Acquisition Speculation Drive Investor Focus

by Robert Sasse
December 18, 2025
0

Abbott Laboratories has announced an increase to its shareholder payout while simultaneously revealing mixed institutional trading activity....

Solana Stock

Solana’s Contradiction: Price Plunge Meets Institutional Embrace

December 18, 2025
QuantumScape Stock

QuantumScape Stock Surges on Major Automotive Partnership

December 18, 2025
Polestar Auto.adr/a Stock

Geely Extends $600 Million Lifeline to Struggling EV Maker Polestar

December 18, 2025
Marvell Technology Stock

Marvell Technology: A Tale of Conflicting Market Signals

December 18, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Abbott Laboratories: Dividend Hike and Acquisition Speculation Drive Investor Focus
  • Solana’s Contradiction: Price Plunge Meets Institutional Embrace
  • QuantumScape Stock Surges on Major Automotive Partnership

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com